Cargando…
Developing a national pharmaceutical research strategy in Lebanon: opportunities to bridge the gaps and reach the goals
Pharmaceutical research can be structured into clear national strategies that optimize patient health and foster innovation. The objectives of this document are to assess the need for a national pharmaceutical research strategy based on the current situation in Lebanon, to identify the strengths and...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672651/ https://www.ncbi.nlm.nih.gov/pubmed/36397120 http://dx.doi.org/10.1186/s40545-022-00485-1 |
_version_ | 1784832784591749120 |
---|---|
author | Akel, Marwan Hajj, Aline Sacre, Hala Zeenny, Rony M. Haddad, Chadia Salameh, Pascale |
author_facet | Akel, Marwan Hajj, Aline Sacre, Hala Zeenny, Rony M. Haddad, Chadia Salameh, Pascale |
author_sort | Akel, Marwan |
collection | PubMed |
description | Pharmaceutical research can be structured into clear national strategies that optimize patient health and foster innovation. The objectives of this document are to assess the need for a national pharmaceutical research strategy based on the current situation in Lebanon, to identify the strengths and weaknesses of pharmaceutical research in Lebanon, and to suggest a pharmaceutical research strategy for Lebanon, including goals and objectives. In Lebanon, in the absence of a national health research policy, pharmaceutical research is conducted in academia or hospitals, although projects are the result of personal or team initiatives that should be organized to better serve the needs of the country. Many strengths of pharmaceutical research were identified, such as the pharmaceutical workforce and academics who are willing to contribute to research, while the implementation of the national pharmaceutical strategy represents an important opportunity to promote research. Among the weaknesses is the lack of research culture in some institutions and interinstitutional/interprofessional collaborations. Thus, the suggested strategy aims to structure pharmaceutical research in Lebanon, including the priorities towards which research is directed, the process by which research is conducted, and the workforce conducting research. It will mainly rely on the World Health Organization's interrelated goals (organization, priorities, capacity, standards, and translation). The implementation of the suggested pharmaceutical research strategy will only be achieved through the leadership of the pharmaceutical authorities and the collaboration of stakeholders. |
format | Online Article Text |
id | pubmed-9672651 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-96726512022-11-18 Developing a national pharmaceutical research strategy in Lebanon: opportunities to bridge the gaps and reach the goals Akel, Marwan Hajj, Aline Sacre, Hala Zeenny, Rony M. Haddad, Chadia Salameh, Pascale J Pharm Policy Pract Commentary Pharmaceutical research can be structured into clear national strategies that optimize patient health and foster innovation. The objectives of this document are to assess the need for a national pharmaceutical research strategy based on the current situation in Lebanon, to identify the strengths and weaknesses of pharmaceutical research in Lebanon, and to suggest a pharmaceutical research strategy for Lebanon, including goals and objectives. In Lebanon, in the absence of a national health research policy, pharmaceutical research is conducted in academia or hospitals, although projects are the result of personal or team initiatives that should be organized to better serve the needs of the country. Many strengths of pharmaceutical research were identified, such as the pharmaceutical workforce and academics who are willing to contribute to research, while the implementation of the national pharmaceutical strategy represents an important opportunity to promote research. Among the weaknesses is the lack of research culture in some institutions and interinstitutional/interprofessional collaborations. Thus, the suggested strategy aims to structure pharmaceutical research in Lebanon, including the priorities towards which research is directed, the process by which research is conducted, and the workforce conducting research. It will mainly rely on the World Health Organization's interrelated goals (organization, priorities, capacity, standards, and translation). The implementation of the suggested pharmaceutical research strategy will only be achieved through the leadership of the pharmaceutical authorities and the collaboration of stakeholders. BioMed Central 2022-11-17 /pmc/articles/PMC9672651/ /pubmed/36397120 http://dx.doi.org/10.1186/s40545-022-00485-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Commentary Akel, Marwan Hajj, Aline Sacre, Hala Zeenny, Rony M. Haddad, Chadia Salameh, Pascale Developing a national pharmaceutical research strategy in Lebanon: opportunities to bridge the gaps and reach the goals |
title | Developing a national pharmaceutical research strategy in Lebanon: opportunities to bridge the gaps and reach the goals |
title_full | Developing a national pharmaceutical research strategy in Lebanon: opportunities to bridge the gaps and reach the goals |
title_fullStr | Developing a national pharmaceutical research strategy in Lebanon: opportunities to bridge the gaps and reach the goals |
title_full_unstemmed | Developing a national pharmaceutical research strategy in Lebanon: opportunities to bridge the gaps and reach the goals |
title_short | Developing a national pharmaceutical research strategy in Lebanon: opportunities to bridge the gaps and reach the goals |
title_sort | developing a national pharmaceutical research strategy in lebanon: opportunities to bridge the gaps and reach the goals |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9672651/ https://www.ncbi.nlm.nih.gov/pubmed/36397120 http://dx.doi.org/10.1186/s40545-022-00485-1 |
work_keys_str_mv | AT akelmarwan developinganationalpharmaceuticalresearchstrategyinlebanonopportunitiestobridgethegapsandreachthegoals AT hajjaline developinganationalpharmaceuticalresearchstrategyinlebanonopportunitiestobridgethegapsandreachthegoals AT sacrehala developinganationalpharmaceuticalresearchstrategyinlebanonopportunitiestobridgethegapsandreachthegoals AT zeennyronym developinganationalpharmaceuticalresearchstrategyinlebanonopportunitiestobridgethegapsandreachthegoals AT haddadchadia developinganationalpharmaceuticalresearchstrategyinlebanonopportunitiestobridgethegapsandreachthegoals AT salamehpascale developinganationalpharmaceuticalresearchstrategyinlebanonopportunitiestobridgethegapsandreachthegoals |